QQ客服 官方微博 反馈留言

	Synthesis, antitumor activity and molecular mechanism of doxorubicin conjugated trimethyl-chitosan polymeric micelle loading Beclin1 siRNA for drug-resisted bladder cancer therapy
	Zhou Zhong; Zhong Cheng; Dongyuan Su; Ting Xu; Xiang Li; Fengbo Wu
刊名	RSC Advances
	2018
卷号	Vol.8 No.62页码:35395-35402
ISSN号	2046-2069
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1832907
专题	四川大学
作者单位	1.a Department of Urology and Department of Orthopaedic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China E-mail: xiangli.87@scu.edu.cn, wfb_sc@ 2.com 3.Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, China 4.Department of Gastroenterology, Chongzhou People's Hospital, Chengdu 611230, China 5.Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China 6.Corresponding authors
推荐引用方式 GB/T 7714	Zhou Zhong,Zhong Cheng,Dongyuan Su,et al. Synthesis, antitumor activity and molecular mechanism of doxorubicin conjugated trimethyl-chitosan polymeric micelle loading Beclin1 siRNA for drug-resisted bladder cancer therapy[J]. RSC Advances,2018,Vol.8 No.62:35395-35402.
APA	Zhou Zhong,Zhong Cheng,Dongyuan Su,Ting Xu,Xiang Li,&Fengbo Wu.(2018).Synthesis, antitumor activity and molecular mechanism of doxorubicin conjugated trimethyl-chitosan polymeric micelle loading Beclin1 siRNA for drug-resisted bladder cancer therapy.RSC Advances,Vol.8 No.62,35395-35402.
MLA	Zhou Zhong,et al."Synthesis, antitumor activity and molecular mechanism of doxorubicin conjugated trimethyl-chitosan polymeric micelle loading Beclin1 siRNA for drug-resisted bladder cancer therapy".RSC Advances Vol.8 No.62(2018):35395-35402.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。